...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZHCLF trading
1
Feb 05, 2021 10:14AM
1
Feb 05, 2021 11:29AM
1
Feb 05, 2021 01:48PM
1
Feb 05, 2021 03:07PM
1
Feb 05, 2021 03:36PM
1
Feb 05, 2021 04:35PM
2
Feb 06, 2021 05:34PM
2
Feb 07, 2021 08:15AM
2
Feb 07, 2021 09:28AM

Is ZCC is a long way off from topline results from where it now stands for it to be a buyout candidate?           Don't know!

ClinicalTrials.gov Identifier: NCT03901469

Official Title: A Phase 2 Study of ZEN003694 in Combination With Talazoparib in Patients With Triple-Negative Breast Cancer
Actual Study Start Date : June 26, 2019
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : January 2022

 

Koo

7
Feb 08, 2021 12:51PM
2
Feb 08, 2021 12:59PM
2
Feb 08, 2021 01:13PM
7
Feb 08, 2021 02:39PM
3
Feb 08, 2021 02:48PM
2
Feb 08, 2021 10:48PM

Feb 09, 2021 08:37AM

Feb 10, 2021 10:54AM
Share
New Message
Please login to post a reply